# Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus

Study · id `cardio:ct-nct01689142` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01689142](<https://clinicaltrials.gov/study/NCT01689142>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01689142

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

## Technical summary

Registry record NCT01689142. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2013-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 240 participants (enrolled count; ClinicalTrials.gov record NCT01689142, source copy `cardio:ctgov-nct01689142-2014-06-05`, retrieved 2026-10-26)
- Start date: 2012-09 (registry gives no type) (ClinicalTrials.gov record NCT01689142, source copy `cardio:ctgov-nct01689142-2014-06-05`, retrieved 2026-10-26)
- Primary completion: 2013-11 (actual) (ClinicalTrials.gov record NCT01689142, source copy `cardio:ctgov-nct01689142-2014-06-05`, retrieved 2026-10-26)
- Completion: 2014-06 (actual) (ClinicalTrials.gov record NCT01689142, source copy `cardio:ctgov-nct01689142-2014-06-05`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01689142, source copy `cardio:ctgov-nct01689142-2014-06-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01689142-2014-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus
- Acronym: EDITION JP II
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Insulin glargine new formulation (HOE901)
- Intervention (Drug): Insulin glargine (HOE901)
- Lead sponsor: Sanofi
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Sanofi (`cardio:org-sanofi`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2) (`cardio:pubmed-26662838`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b827f29b2b4973ee29dc8aee59958de80895010d06805b13621d3134b6a509c2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
